EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Receptor-Assisted Nanotherapeutics for Overcoming the Blood–Brain Barrier

Akshada Mhaske, Shalini Shukla, Kailash Ahirwar, Kamalinder K Singh, Rahul Shukla

Molecular Neurobiology · 2024-11 · 61 (11) · 8702-8738

DOI: 10.1007/s12035-024-04015-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Neurobiology, online erschienen am 01.04.2024. Verfasst von Akshada Mhaske und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Raebareli, Bijnor-Sisendi Road, Sarojini Nagar, Luck…. Hauptthemen laut MEDLINE: Blood-Brain Barrier. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blood–brain barrier (BBB) is a distinguishing checkpoint that segregates peripheral organs from neural compartment. It protects the central nervous system from harmful ambush of antigens and pathogens. Owing to such explicit selectivity, the BBB hinders passage of various neuroprotective drug molecules that escalates into poor attainability of neuroprotective agents towards the brain. However, few molecules can surpass the BBB and gain access in the brain parenchyma by exploiting surface transporters and receptors. For successful development of brain-targeted therapy, understanding of BBB transporters and receptors is crucial. This review focuses on the transporter and receptor–based mechanistic pathway that can be manoeuvred for better comprehension of reciprocity of receptors and nanotechnological vehicle delivery. Nanotechnology has emerged as one of the expedient noninvasive approaches for brain targeting via manipulating the hurdle of the BBB. Various nanovehicles are being reported for brain-targeted delivery such as nanoparticles, nanocrystals, nanoemulsion, nanolipid carriers, liposomes and other nanovesicles. Nanotechnology-aided brain targeting can be a strategic approach to circumvent the BBB without altering the inherent nature of the BBB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierHumansAnimalsDrug Delivery SystemsNanoparticlesReceptors, Cell SurfaceBiological TransportNanotechnology

Stichwörter der Autor:innen

BBB disruptionBlood–brain barrierNanomedicineNanotechnologyReceptorsTransporters

Substanzen

Receptors, Cell Surface

Autor:innen und Institutionen

  • Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Raebareli, Bijnor-Sisendi Road, Sarojini Nagar, Lucknow, Uttar Pradesh, 226002, India.
  • School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, PR1 2HE, UK. ksingh1@uclan.ac.uk.
  • Biomedical Evidence-based Transdisciplinary Health Research Institute, University of Central Lancashire, Preston, PR1 2HE, UK. ksingh1@uclan.ac.uk.
  • Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Raebareli, Bijnor-Sisendi Road, Sarojini Nagar, Lucknow, Uttar Pradesh, 226002, India. rahul.shukla@niperraebareli.edu.in.

Zitieren

APA

Mhaske, A., Shukla, S., Ahirwar, K., Singh, K. K., & Shukla, R. (2024). Receptor-Assisted Nanotherapeutics for Overcoming the Blood–Brain Barrier. Molecular Neurobiology, 61(11), 8702-8738. https://doi.org/10.1007/s12035-024-04015-9

Vancouver

Mhaske A, Shukla S, Ahirwar K, Singh KK, Shukla R. Receptor-Assisted Nanotherapeutics for Overcoming the Blood–Brain Barrier. Molecular Neurobiology. 2024;61(11):8702-8738. doi:10.1007/s12035-024-04015-9

BibTeX
@article{Mhaske2024,
  author = {Mhaske, Akshada and Shukla, Shalini and Ahirwar, Kailash and Singh, Kamalinder K and Shukla, Rahul},
  title = {Receptor-Assisted Nanotherapeutics for Overcoming the Blood–Brain Barrier},
  journal = {Molecular Neurobiology},
  year = {2024},
  volume = {61},
  number = {11},
  pages = {8702--8738},
  doi = {10.1007/s12035-024-04015-9}
}
Kostenlos starten →